Correction to: Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
- PMID: 38108764
- PMCID: PMC10821356
- DOI: 10.1093/eurheartj/ehad854
Correction to: Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
Erratum for
-
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.Eur Heart J. 2023 Nov 21;44(44):4622-4633. doi: 10.1093/eurheartj/ehad637. Eur Heart J. 2023. PMID: 37804245 Free PMC article. Review.
